封面
市场调查报告书
商品编码
1476346

到 2030 年兽医参考实验室市场预测:按服务类型、动物类型、应用、最终用户和地区进行的全球分析

Veterinary Reference Laboratory Market Forecasts to 2030 - Global Analysis By Service Type, Animal Type, Application, End User and by Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,2023 年全球兽医参考实验室市场规模为 45.6 亿美元,预计到 2030 年将达到 96.5 亿美元,预测期内复合年增长率为 11.3%。

兽医参考实验室 (VRL) 是一个专业设施,拥有最先进的设备和高素质的兽医专业人员,致力于诊断和追踪动物的健康状况。血液化学分析、微生物学、病理学和基因检测只是 VRL 帮助诊断和治疗各种动物疾病的众多测试中的一小部分。 VRL 是保护动物健康、帮助研究并确保家畜和野生动物福利的重要资源。

英国兽医协会 (BVA) 表示,兽医专业人员致力于促进动物的健康和福祉、推动兽医医学发展并维护高标准的专业行为。

动物健康意识不断增强

兽医协会、动物福利组织和政府机构等相关人员越来越多地合作,以提高动物健康意识。这些计划的目标是提高宠物饲主和牲畜生产者对定期兽医检查和预防性医疗保健措施价值的认识。此外,最近爆发的禽流感和牛脑病变(BSE)等备受瞩目的疾病进一步强调了对强有力的诊断服务的需求,并强调了损害动物健康和食品安全所带来的风险。

尖端诊断技术成本高

兽医参考实验室在实施新诊断技术方面面临重大财务障碍。购买最先进的设备(例如自动分析仪和次世代定序平台)相关的初始成本很高。由于设备升级、校准和维护的持续支出,营运成本也会增加。此外,需要雇用和维持能够熟练使用和解释这些最尖端科技产生的资料的合格员工,这进一步增加了财务负担。

对专业诊断服务的需求不断增加

兽医学的日益复杂性以及动物感染疾病和慢性病发病率的上升为兽医参考实验室提供了扩大其服务范围的机会。分子诊断、血清学和先进影像等专业诊断测试作为早期发现疾病、制定个人化治疗计划和监测治疗效果的工具的需求不断增加。此外,实验室可以利用这一趋势,透过投资尖端技术并提高基因检测、感染疾病和肿瘤学等专业领域的能力,在市场中脱颖而出。

来自针对竞争对手的内部测试的压力

为了提高交货时间和客户满意度,兽医医院和诊所正在增加诊断测试设备的内部投资。由于这一趋势,兽医参考实验室陷入危机,因为委託给外部实验室的诊断测试越来越少。兽医院可能会发现院内检测更实用、更经济,特别是对于快速诊断检测和常规筛检检测。然而,为了减少内部测试的竞争影响,兽医参考实验室必须透过提供专业测试、复杂病例知识和卓越的客户服务来脱颖而出。

COVID-19 的影响:

兽医参考实验室市场受到了 COVID-19 大流行的影响。儘管在大流行的早期阶段,实验室运营中断、供应链挑战以及封锁措施和经济不确定性减少了对非必要兽医服务的需求,但大流行的下一阶段是随着趋势的变化而逐步復苏。这次疫情凸显了兽医诊断在通用感染疾病监测、动物健康监测和食品安全方面的价值,并增加了对诊断检测服务的需求。此外,由于疫情期间宠物饲养量的增加以及对动物健康和福利意识的增强,对健康检查、疫苗接种和诊断筛检等预防性医疗的需求也在增加。

在预测期内,临床病理学领域预计将是最大的。

在兽医参考实验室产业,临床病理学领域预计将占据最大的市场占有率。临床病理学是一个广泛的医学领域,包括透过检查动物的组织、细胞和体液来评估动物健康状况的各种诊断程序。血液学、生物化学、尿液检查、细胞学和组织病理学是其中的一些测试。此外,多种兽医疾病的诊断、监测和治疗,包括感染疾病、传染性疾病、免疫介导疾病和肿瘤疾病,在很大程度上依赖临床病理学。

预计製药领域在预测期内复合年增长率最高

在兽医参考实验室市场,製药公司领域预计将出现最高的复合年增长率。透过兽药、疫苗和生物製药的开发和开拓,製药公司在兽药领域发挥重要作用。我们依靠兽医参考实验室提供临床前和临床测试服务来评估我们产品的安全性、有效性和品质。此外,兽医参考实验室和製药公司合作进行研究和开发计划,以推进兽医诊断和治疗方法。

占比最大的地区:

由于其强大的法律规范、最先进的诊断技术以及完善的兽医医疗保健基础设施(兽医诊所、医院和研究机构高度集中),北美通常占据最大份额。对诊断测试服务的需求部分是由于北美宠物拥有量的增加、对伴同性动物医疗保健服务的需求增加以及公众对通用感染疾病的认识提高而推动的。此外,政府机构、兽医协会和市场参与企业在推广预防医学和改善动物福利方面的刻意努力也有助于该地区兽医参考实验室市场的稳定扩张。

复合年增长率最高的地区:

兽医参考实验室市场预计将以亚太地区最高的复合年增长率成长。新兴经济体,特别是中国、印度和东南亚国家,正在经历快速的都市化、经济发展和向伴同性动物养殖的转变。可支配收入的增加、生活方式的变化以及宠物健康意识的提高正在推动该地区对兽医健康服务(包括诊断测试)的需求。畜牧业生产的扩大以及对食品安全和疾病爆发的日益担忧推动了兽医保健中先进诊断技术的采用。此外,由于政府改善动物福利、加强法规结构和实现动物保健基础设施现代化的倡议,亚太兽医参考实验室市场正在扩大。

免费客製化服务:

订阅此报告的客户将收到以下免费自订选项之一:

  • 公司简介
    • 其他市场参与者的综合分析(最多 3 家公司)
    • 主要企业SWOT分析(最多3家企业)
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率(註:基于可行性检查)
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第四章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球兽医参考实验室市场:依服务类型

  • 临床化学
  • 免疫诊断
    • ELISA
    • 横向流动化验
  • 分子诊断
    • PCR检测
    • 微阵列
  • 血液学
  • 尿液检查
  • 其他服务类型

第六章全球兽医参考实验室市场:依动物类型

  • 宠物
  • 家畜
    • 家禽
  • 其他动物类型

第七章全球兽医参考实验室市场:依应用分类

  • 临床病理学
  • 细菌学
  • 寄生虫学
  • 病毒学
  • 生产力测试
  • 怀孕测试
  • 毒性试验
  • 其他用途

第八章全球兽医参考实验室市场:依最终用户分类

  • 兽医诊所和医院
  • 研究机构和大学
  • 製药公司
  • 政府和监管机构
  • 其他最终用户

第九章全球兽医参考实验室市场:按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • ProtaTek International Inc
  • GreenCross Limited
  • VCA Inc
  • ANTECH Diagnostics
  • Neogen Corporation
  • Thermo Fisher Scientific, Inc.
  • IDEXX Laboratories, Inc.
  • GD Animal Health
  • Marshfield Labs
  • Zoetis Inc
  • SYNLAB International GmbH
  • Heska Corporation
  • Texas A&M Veterinary Medical Diagnostic Laboratory
  • LABOKLIN GmbH
Product Code: SMRC25892

According to Stratistics MRC, the Global Veterinary Reference Laboratory Market is accounted for $4.56 billion in 2023 and is expected to reach $9.65 billion by 2030 growing at a CAGR of 11.3% during the forecast period. A Veterinary Reference Laboratory (VRL) is a specialized facility with cutting-edge equipment and highly qualified veterinary professionals working there to diagnose and track the health of animals. These labs are vital resources for veterinarians and other animal health professionals because they offer prompt and accurate diagnostic services, blood chemistry analysis, microbiology, pathology, and genetic testing are just a few of the many tests that VRLs provide to help with the diagnosis and treatment of various animal diseases. They are vital resources that protect the health of animals, aid in research, and guarantee the welfare of domestic and wild animals.

According to the British Veterinary Association (BVA), Veterinary professionals are committed to promoting the health and welfare of animals, advancing veterinary science, and upholding high standards of professional conduct.

Market Dynamics:

Driver:

Increasing awareness of animal health

A growing number of stakeholders, including veterinary associations, animal welfare organizations, and governmental bodies, are working together to raise awareness about animal health. The purpose of these programs is to raise awareness among pet owners and livestock producers of the value of regular veterinary checkups and preventive healthcare measures. Additionally, the need for strong diagnostic services has been further highlighted by high-profile disease outbreaks in recent years, including avian influenza and bovine spongiform encephalopathy (BSE), which have highlighted the risks associated with compromised animal health and food safety.

Restraint:

High expense of cutting-edge diagnostic technologies

Veterinary Reference Laboratories faces a substantial financial hurdle in implementing new diagnostic technologies. The upfront costs associated with purchasing cutting-edge machinery, like automated analyzers and next-generation sequencing platforms, can be high. The operational costs are also increased by continuing expenditures for equipment upgrades, calibration, and maintenance. Furthermore, the financial burden is further increased by the need to hire and retain qualified staff that is adept at using and interpreting the data from these advanced technologies.

Opportunity:

Growing requirement for diagnostic specialty services

Veterinary Reference Laboratories has the opportunity to broaden the scope of their services due to the growing complexity of veterinary care and the rise in the incidence of infectious and chronic diseases in animals. Specialized diagnostic tests, like molecular diagnostics, serology, and advanced imaging, are in greater demand as a means of enabling early disease detection, individualized treatment planning, and therapeutic efficacy monitoring. Moreover, labs can take advantage of this trend and set themselves apart in the market by investing in state-of-the-art technologies and building competence in specialized fields like genetic testing, infectious diseases, and oncology.

Threat:

Pressure from in-house testing for competition

To increase turnaround times and client satisfaction, veterinary clinics and hospitals are investing more and more in internal diagnostic testing equipment. As a result of this trend, veterinary reference laboratories are at risk because fewer diagnostic tests are being contracted out to outside laboratories. Veterinary clinics may find that in-house testing is more practical and economical, especially when it comes to fast diagnostic assays and routine screenings. However, to lessen the impact of competition from in-house testing, Veterinary Reference Laboratories must set themselves apart from the competition by providing specialized tests, knowledge of intricate cases, and exceptional customer service.

Covid-19 Impact:

The Veterinary Reference Laboratory market has been impacted by the COVID-19 pandemic. In the following phases of the pandemic, there has been a gradual recovery with changing trends, whereas the initial phase of the pandemic caused disruptions in laboratory operations, challenges in the supply chain, and decreased demand for non-essential veterinary services due to lockdown measures and economic uncertainties. The pandemic has increased demand for diagnostic testing services by highlighting the value of veterinary diagnostics in zoonotic disease surveillance, animal health monitoring, and ensuring food safety. Additionally, the demand for preventive healthcare procedures like wellness exams, vaccinations, and diagnostic screenings has increased due to the rise in pet ownership and the increased awareness of animal health and well-being during the pandemic.

The Clinical Pathology segment is expected to be the largest during the forecast period

It is projected that the clinical pathology segment will command the largest market share in the veterinary reference laboratory industry. Clinical pathology is a wide field of medicine that includes a variety of diagnostic procedures used to evaluate the health of animals by examining their tissues, cells, and bodily fluids. Hematology, biochemistry, urinalysis, cytology, and histopathology are a few of these tests. Furthermore, the diagnosis, surveillance, and treatment of a wide range of animal medical disorders, such as metabolic disorders, infectious diseases, immune-mediated disorders, and neoplastic diseases, depend heavily on clinical pathology.

The Pharmaceutical Companies segment is expected to have the highest CAGR during the forecast period

In the Veterinary Reference Laboratory market, the pharmaceutical company segment is projected to have the highest CAGR. Through the development and marketing of veterinary medications, vaccines, and biological products, pharmaceutical companies play a crucial role in veterinary medicine. For preclinical and clinical testing services to evaluate the safety, effectiveness, and caliber of their products, they depend on Veterinary Reference Laboratories. Moreover, reference laboratories and pharmaceutical companies work together on research and development projects that progress veterinary diagnostics and therapies.

Region with largest share:

North America usually holds the largest share, with strong regulatory frameworks and cutting-edge diagnostic technologies, the region has a well-established veterinary healthcare infrastructure that includes a high concentration of veterinary clinics, hospitals, and research institutions. The need for diagnostic testing services is driven in part by growing pet ownership, increased demand for companion animal healthcare services, and increased public awareness of zoonotic diseases in North America. Furthermore, deliberate efforts by governmental organizations, veterinary associations, and industry participants to advance preventive healthcare practices and improve animal welfare also contribute to the region's Veterinary Reference Laboratory market's steady expansion.

Region with highest CAGR:

The Veterinary Reference Laboratory market is expected to grow at the highest CAGR in the Asia-Pacific region. Particularly in emerging economies like China, India, and Southeast Asian nations, the region is seeing rapid urbanization, economic development, and a shift toward companion animal ownership. The demand in the area for veterinary services, including diagnostic testing, is being driven by rising disposable incomes, evolving lifestyles, and an increasing consciousness of pet health. The adoption of advanced diagnostic technologies in veterinary healthcare is being driven by the expansion of livestock production and growing concerns about food safety and disease outbreaks. Moreover, the Veterinary Reference Laboratory market in Asia Pacific is expanding as a result of government initiatives to improve animal welfare, bolster regulatory frameworks, and modernize the infrastructure for animal healthcare.

Key players in the market

Some of the key players in Veterinary Reference Laboratory market include ProtaTek International Inc, GreenCross Limited, VCA Inc, ANTECH Diagnostics, Neogen Corporation, Thermo Fisher Scientific, Inc., IDEXX Laboratories, Inc., GD Animal Health, Marshfield Labs, Zoetis Inc, SYNLAB International GmbH, Heska Corporation, Texas A&M Veterinary Medical Diagnostic Laboratory and LABOKLIN GmbH.

Key Developments:

In June 2023, Antech Diagnostics, Inc. made a proposal to acquire Heska Corporation from BlackRock, Inc., The Vanguard Group, Inc. and others for $1.4 billion on February 20, 2023. As part of consideration Antech Diagnostics will pay in all cash, at a price of $112.50 per share. On March 6, 2023, Mars submitted to Heska a revised written proposal to acquire Heska in an all-cash transaction at a price of $120 per share.

In April 2023, Neogen Chemicals Ltd., a manufacturer of Bromine-based and Lithium-based specialty chemicals, said it has signed an agreement with MU Ionic Solutions Corporation (MUIS), Japan, to acquire manufacturing technology licence for production of electrolytes in India. MUIS is a joint-venture between Mitsubishi Chemical Corporation (MCC) and UBE Corporation, a group company of The Mitsubishi Chemicals Group.

In February 2023, Thermo Fisher Scientific Inc. entered into a definitive agreement to acquire CorEvitas, a provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity, for $912.5 million in cash. CorEvitas will become part of Thermo Fisher's Laboratory Products and Biopharma Services segment. The transaction is expected to be completed by the end of 2023.

Service Types Covered:

  • Clinical Chemistry
  • Immunodiagnostics
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Other Service Types

Animal Types Covered:

  • Companion Animals
  • Livestock Animals
  • Other Animal Types

Applications Covered:

  • Clinical Pathology
  • Bacteriology
  • Parasitology
  • Virology
  • Productivity Testing
  • Pregnancy Testing
  • Toxicology Testing
  • Other Applications

End Users Covered:

  • Veterinary Clinics and Hospitals
  • Research Institutions and Universities
  • Pharmaceutical Companies
  • Government Agencies and Regulatory Bodies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Veterinary Reference Laboratory Market, By Service Type

  • 5.1 Introduction
  • 5.2 Clinical Chemistry
  • 5.3 Immunodiagnostics
    • 5.3.1 ELISA
    • 5.3.2 Lateral Flow Assays
  • 5.4 Molecular Diagnostics
    • 5.4.1 PCR Tests
    • 5.4.2 Microarrays
  • 5.5 Hematology
  • 5.6 Urinalysis
  • 5.7 Other Service Types

6 Global Veterinary Reference Laboratory Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Companion Animals
    • 6.2.1 Dogs
    • 6.2.2 Cats
    • 6.2.3 Horses
  • 6.3 Livestock Animals
    • 6.3.1 Cattle
    • 6.3.2 Swine
    • 6.3.3 Poultry
  • 6.4 Other Animal Types

7 Global Veterinary Reference Laboratory Market, By Application

  • 7.1 Introduction
  • 7.2 Clinical Pathology
  • 7.3 Bacteriology
  • 7.4 Parasitology
  • 7.5 Virology
  • 7.6 Productivity Testing
  • 7.7 Pregnancy Testing
  • 7.8 Toxicology Testing
  • 7.9 Other Applications

8 Global Veterinary Reference Laboratory Market, By End User

  • 8.1 Introduction
  • 8.2 Veterinary Clinics and Hospitals
  • 8.3 Research Institutions and Universities
  • 8.4 Pharmaceutical Companies
  • 8.5 Government Agencies and Regulatory Bodies
  • 8.6 Other End Users

9 Global Veterinary Reference Laboratory Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 ProtaTek International Inc
  • 11.2 GreenCross Limited
  • 11.3 VCA Inc
  • 11.4 ANTECH Diagnostics
  • 11.5 Neogen Corporation
  • 11.6 Thermo Fisher Scientific, Inc.
  • 11.7 IDEXX Laboratories, Inc.
  • 11.8 GD Animal Health
  • 11.9 Marshfield Labs
  • 11.10 Zoetis Inc
  • 11.11 SYNLAB International GmbH
  • 11.12 Heska Corporation
  • 11.13 Texas A&M Veterinary Medical Diagnostic Laboratory
  • 11.14 LABOKLIN GmbH

List of Tables

  • Table 1 Global Veterinary Reference Laboratory Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Veterinary Reference Laboratory Market Outlook, By Service Type (2021-2030) ($MN)
  • Table 3 Global Veterinary Reference Laboratory Market Outlook, By Clinical Chemistry (2021-2030) ($MN)
  • Table 4 Global Veterinary Reference Laboratory Market Outlook, By Immunodiagnostics (2021-2030) ($MN)
  • Table 5 Global Veterinary Reference Laboratory Market Outlook, By ELISA (2021-2030) ($MN)
  • Table 6 Global Veterinary Reference Laboratory Market Outlook, By Lateral Flow Assays (2021-2030) ($MN)
  • Table 7 Global Veterinary Reference Laboratory Market Outlook, By Molecular Diagnostics (2021-2030) ($MN)
  • Table 8 Global Veterinary Reference Laboratory Market Outlook, By PCR Tests (2021-2030) ($MN)
  • Table 9 Global Veterinary Reference Laboratory Market Outlook, By Microarrays (2021-2030) ($MN)
  • Table 10 Global Veterinary Reference Laboratory Market Outlook, By Hematology (2021-2030) ($MN)
  • Table 11 Global Veterinary Reference Laboratory Market Outlook, By Urinalysis (2021-2030) ($MN)
  • Table 12 Global Veterinary Reference Laboratory Market Outlook, By Other Service Types (2021-2030) ($MN)
  • Table 13 Global Veterinary Reference Laboratory Market Outlook, By Animal Type (2021-2030) ($MN)
  • Table 14 Global Veterinary Reference Laboratory Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 15 Global Veterinary Reference Laboratory Market Outlook, By Dogs (2021-2030) ($MN)
  • Table 16 Global Veterinary Reference Laboratory Market Outlook, By Cats (2021-2030) ($MN)
  • Table 17 Global Veterinary Reference Laboratory Market Outlook, By Horses (2021-2030) ($MN)
  • Table 18 Global Veterinary Reference Laboratory Market Outlook, By Livestock Animals (2021-2030) ($MN)
  • Table 19 Global Veterinary Reference Laboratory Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 20 Global Veterinary Reference Laboratory Market Outlook, By Swine (2021-2030) ($MN)
  • Table 21 Global Veterinary Reference Laboratory Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 22 Global Veterinary Reference Laboratory Market Outlook, By Other Animal Types (2021-2030) ($MN)
  • Table 23 Global Veterinary Reference Laboratory Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 Global Veterinary Reference Laboratory Market Outlook, By Clinical Pathology (2021-2030) ($MN)
  • Table 25 Global Veterinary Reference Laboratory Market Outlook, By Bacteriology (2021-2030) ($MN)
  • Table 26 Global Veterinary Reference Laboratory Market Outlook, By Parasitology (2021-2030) ($MN)
  • Table 27 Global Veterinary Reference Laboratory Market Outlook, By Virology (2021-2030) ($MN)
  • Table 28 Global Veterinary Reference Laboratory Market Outlook, By Productivity Testing (2021-2030) ($MN)
  • Table 29 Global Veterinary Reference Laboratory Market Outlook, By Pregnancy Testing (2021-2030) ($MN)
  • Table 30 Global Veterinary Reference Laboratory Market Outlook, By Toxicology Testing (2021-2030) ($MN)
  • Table 31 Global Veterinary Reference Laboratory Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 32 Global Veterinary Reference Laboratory Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Global Veterinary Reference Laboratory Market Outlook, By Veterinary Clinics and Hospitals (2021-2030) ($MN)
  • Table 34 Global Veterinary Reference Laboratory Market Outlook, By Research Institutions and Universities (2021-2030) ($MN)
  • Table 35 Global Veterinary Reference Laboratory Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 36 Global Veterinary Reference Laboratory Market Outlook, By Government Agencies and Regulatory Bodies (2021-2030) ($MN)
  • Table 37 Global Veterinary Reference Laboratory Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.